Abstract: A method for in vivo electrotherapy, or electroporation-mediated therapy, using a needle array apparatus is provided. Treatment of tumors with a combination of electroporation using the apparatus of the invention, and a chemotherapeutic agent, caused regression of tumors in vivo.
Type:
Grant
Filed:
April 18, 2000
Date of Patent:
July 9, 2002
Assignee:
Genetronics, Inc.
Inventors:
Gunter A. Hofmann, Richard A. Gilbert, Richard Heller, Mark J. Jaroszeski
Abstract: A method for producing a neuroblast and a cellular composition comprising an enriched population of neuroblast cells is provided. Also disclosed are methods for identifying compositions which affect neuroblast and for treating a subject with a neuronal disorder, and a culture system for the production and maintenance of neuroblasts.
Type:
Grant
Filed:
June 27, 1997
Date of Patent:
July 24, 2001
Assignee:
The Regents of the University of California
Abstract: The present invention provides two novel polypeptides, referred to as the “N” and “C” fragments of hedgehog, or N-terminal and C-terminal fragments, respectively, which are derived after specific cleavage at a Gly↓Cys Phe site recognized by the autoproteolytic domain in the native protein. Methods of identifying compositions which affect hedgehog activity based on inhibition of cholesterol modification of hedgehog protein are described. Also provided are methods of use of the N and C fragments.
Type:
Grant
Filed:
October 7, 1996
Date of Patent:
April 10, 2001
Assignees:
The Johns Hopkins University School of Medicine, University of Washington
Inventors:
Philip A. Beachy, Randall T. Moon, Jeffrey A. Porter
Abstract: A method for diagnosing a congenital disease by determining a cell's response to activation of a membrane receptor using a physiological indicator is provided. The method of the invention uses fetal or adult cells in a non-invasive screen for congenital disorders.
Abstract: A method for producing a neuroblast and a cellular composition comprising an enriched population of neuroblast cells is provided. Also disclosed are methods for identifying compositions which affect neuroblasts and for treating a subject with a neuronal disorder, and a culture system for the production and maintenance of neuroblasts.